SlideShare a Scribd company logo
1 of 40
DCM2:1
PATHOLOGY LECTURE NOTES




                           1
DEFINITIONS
 Exudation: Escape of fluid, proteins and blood cells
  from the vascular system into the interstitial tissue or
  body cavities.
 Exudate: an inflammatory extra vascular fluid that
  has high protein concentration and much cellular
  debris.
 Edema: an excess of fluid in the interstitial tissue or
  serous cavities.



                                                             2
Introduction
 Inflammation is the reaction of vascularized living
  tissue to local injury.
 It is evoked by:
    Microbial infections
    Physical agents
    Chemicals
    Necrotic tissue
    Immunologic reactions




                                                        3
Introduction
 The roles of inflammation are:
    To contain and isolate injury
    To destroy invading microorganisms
    To inactivate toxins
    To prepare the tissue or organ for healing and repair




                                                             4
Acute Inflammation
 Acute inflammation is a rapid response to an injurious
  agent that serves to deliver mediators of host
  defense—leukocytes and plasma proteins—to the site
  of injury.
 When a host encounters an injurious
  agent, phagocytes that reside in all tissues try to get rid
  of these agents.




                                                                5
Acute Inflammation
 At the same time, phagocytes and other host cells react
  to the presence of the foreign or abnormal substance
  by liberating cytokines, lipid messengers, and the
  various other mediators of inflammation.
 Some of these mediators act on endothelial cells in the
  vicinity and promote the efflux of plasma and the
  recruitment of circulating leukocytes to the site where
  the offending agent is located.



                                                            6
Acute Inflammation - continued
 As the injurious agent is eliminated and anti-
  inflammatory mechanisms become active, the
  process subsides and the host returns to a normal
  state of health.
 If the injurious agent cannot be quickly
  eliminated, the result may be chronic
  inflammation.



                                                      7
Acute Inflammation
 Acute inflammation has three major components:
   alterations in vascular caliber that lead to an increase in
    blood flow;
   structural changes in the microvasculature that permit
    plasma proteins and leukocytes to leave the circulation;
    and
   emigration of the leukocytes from the
    microcirculation, their accumulation in the focus of
    injury, and their activation to eliminate the offending

    agent
                                                                  8
Acute Inflammation
 These changes produce the classic clinical signs of
 inflammation:
   Heat (Calor)
   Redness (Rubor)
   Edema (tumor)
   Pain (dolor)
   Loss of function




                                                        9
10
 Acute inflammatory reactions are triggered by a
 variety of stimuli:
 Infections (bacterial, viral, parasitic) and microbial
 toxins
 • Trauma (blunt and penetrating)
 • Physical and chemical agents (thermal injury, e.g.,
 burns or frostbite; irradiation; some environmental
 chemicals)
 • Tissue necrosis (from any cause)
 • Foreign bodies (splinters, dirt, sutures)
 • Immune reactions (also called hypersensitivity
 reactions)


                                                          11
Changes in vascular flow and
caliber
 Initially, transient vasoconstriction of arterioles occurs
 Vasodilation follows, causing increased flow; it
  accounts for the heat and redness
 Eventually slowing of the circulation occurs as a result
  of increased vascular permeability, leading to stasis.
  (edema)
 With slowing, leukocytic margination appears.




                                                               12
13
Vasodilation
 Brief arteriolar vasoconstriction followed by
 vasodilation
   Accounts for warmth and redness
   Opens microvascular beds
   Increased intravascular pressure causes an early
    transudate (protein-poor filtrate of plasma) into
    interstitium (vascular permeability still not increased
    yet)
Increased vascular permeability
 Leads to escape of protein rich fluid into the
  intestitium.
 There is increased hydrostatic pressure, caused by
  vasodilatation, decreased osmotic pressure due to
  leakage of a high protein fluid, resulting in marked
  outflow of fluid and edema formation.




                                                         15
Vascular leakage
 Five mechanisms known to cause vascular
  leakiness
   Histamines, bradykinins, leukotrienes cause an
   early, brief (15 – 30 min.) immediate transient
   response in the form of endothelial cell
   contraction that widens intercellular gaps of
   venules (not arterioles, capillaries)
Vascular leakage
  Cytokine mediators (TNF, IL-1) induce
   endothelial cell junction retraction through
   cytoskeleton reorganization (4 – 6 hrs post
   injury, lasting 24 hrs or more)
  Severe injuries may cause immediate direct
   endothelial cell damage (necrosis, detachment)
   making them leaky until they are repaired
   (immediate sustained response), or may cause
   delayed damage as in thermal or UV injury,
Vascular leakage
  (cont’d) or some bacterial toxins (delayed
   prolonged leakage)
  Marginating and endothelial cell-adherent
   leukocytes may pile-up and damage the
   endothelium through activation and release of
   toxic oxygen radicals and proteolytic enzymes
   (leukocyte-dependent endothelial cell injury)
   making the vessel leaky
Vascular leakage
   Certain mediators (VEGF) may cause increased
     transcytosis via intracellular vesicles which
     travel from the luminal to basement membrane
     surface of the endothelial cell
 All or any combination of these events may occur
  in response to a given stimulus
Cellular events: Leukocyte
extravasation and phagocytosis
 Delivers leukocytes to the site of injury.
 Sequence of events can be divided into:
    Margination, rolling and adhesion to the lumen
    Diapedesis
    Migration in the endothelial tissues towards a
     chemotactic stimulus.




                                                      20
Adhesion and Transmigration
 Occurs as a result of interaction between adhesion
  molecules on the leukocytes and endothelium.
 Major ligand-receptor pairs include:
   Selectins (E, P and L)
   Immunoglobulins family: ICAM and VCAM-1
   The integrins




                                                       21
Leukocytes Rolling Within a Venule




                                     22
Neutrophil Pavementing (lining the venule)
                                             23
Neutrophil Transendothelial Migration (Diapedesis)




                                                     24
25
Chemotaxis and leukocyte
activation
 Adherent leukocytes emigrate through
  interendothelial junctions, traverse the basement
  membrane and move towards the site of injury along a
  gradient of chemotactic agents.
 Neutrophils emigrate first and they are followed by
  monocytes and lymphocytes.




                                                         26
Chemotaxis and leukocyte
activation
 Chemotactic agents include: bacterial
  products, complement fragments
  (C5a), leukotrienes, and chemokines (IL-8).
 These agents bind to specific receptors on
  leukocyte, resulting in signal transduction
  process, which results in assembly of the contractile
  elements responsible for cell movement.




                                                          27
28
Chemotaxis and leukocyte
activation
 Chemotactic agents also cause leukocyte activation
 characterized by:
   Degranulation and secretion of enzymes
   Activation of an oxidative burst
   Production of arachidonic acid metabolites
   Modulation of leukocyte adhesion molecules




                                                       29
Phagocytosis
 Involves 3 steps:
    Recognition and attachment of the paricle to be
     ingested. Facilitated by opsonization e.g. Fc fragment of
     IgG.
    Engulfment by pseudopods, with formation of a
     phagocytic vesicle, which fuses with membrane of the
     lysosome to form a phagolysosome.
    Killing and degranulation of bacteria.




                                                                 30
Phagocytosis
 There are 2 types of bactericidal mechanisms:
 Oxygen dependent mechanisms: this involves
  production of reactive oxygen species catalysed by
  enzymes such as: NADPH oxidase and
  myeloperoxidase
 Oxygen independent mechanisms: these cause
  increased permeability of the bacterial cell membrane.




                                                           31
32
Oxidative burst
 Reactive oxygen species formed through oxidative
 burst that includes:
   Increased oxygen consumption
   Glycogenolysis
   Increased glucose oxidation
   Formation of superoxide ion
     2O2 + NADPH  2O2-rad + NADP+ + H+
      (NADPH oxidase)
     O2 + 2H+  H2O2 (dismutase)
Reactive oxygen species
 Hydrogen peroxide alone insufficient
 Myeloperoxidase oxidase (azurophilic granules)
  converts hydrogen peroxide to HOCl- (in presence of
  Cl- ), an oxidant/antimicrobial agent
 Therefore, PMNs can kill by halogenation, or
  lipid/protein peroxidation
Degradation and Clean-up
 Reactive end-products only active within
  phagolysosome
 Hydrogen peroxide broken down to water and oxygen
  by catalase
 Dead microorganisms degraded by lysosomal acid
  hydrolases
Leukocyte granules
 Other antimicrobials in leukocyte granules:
   Bactericidal permeability increasing protein (BPI)
   Lysozyme
   Lactoferrin
   Defensins (punch holes in membranes)
Leukocyte induced tissue injury
 Leukocytes also release some of their products into the
 extracellular space. These include:
   Lysosomal enzymes
   Oxygen derived active metabolites
   Products of arachidonic acid metabolism such as
    prostaglandins and leukotrienes.
 these may cause tissue damage and if persistent may
 result in chronic inflammation.



                                                        37
Defects in leukocyte function
 May interfere with inflammation and increase
  susceptibility to infection.
 They may be :
   Acquired such as neutropenia
   Genetic such as:
        Defects in leukocyte adhesion
        Defects in phagocytosis such as Chediak-Higashi syndrome
        Defects in microbicidal activity




                                                                    38
Defects of leukocyte function
 Defects of adhesion:
   Defect in E- and P-selectin sugar epitopes (LAD-2)
 Defects of chemotaxis/phagocytosis:
   Microtubule assembly defect leads to impaired
    locomotion and lysosomal degranulation (Chediak-
    Higashi Syndrome)
 Defects of microbicidal activity:
   Deficiency of NADPH oxidase that generates
    superoxide, therefore no oxygen-dependent killing
    mechanism (chronic granulomatous disease)
Outcome of acute inflammation
 Complete resolution with restoration of the site to
  normal
 Abscess formation
 Healing by connective tissue replacement (fibrosis)
  and scarring.
 Progression to chronic inflammation.




                                                        40

More Related Content

What's hot

Inflamation ppt
Inflamation pptInflamation ppt
Inflamation ppt
Srota Dawn
 
1. inflammation with vascular events dr ashutosh kumar
1. inflammation  with vascular events dr ashutosh kumar1. inflammation  with vascular events dr ashutosh kumar
1. inflammation with vascular events dr ashutosh kumar
DrAshutosh Kumar
 
Cellular responses to stress and noxious stimuli
Cellular responses to stress and noxious stimuliCellular responses to stress and noxious stimuli
Cellular responses to stress and noxious stimuli
Aj Cocjin
 

What's hot (20)

Inflammation
InflammationInflammation
Inflammation
 
Inflamation ppt
Inflamation pptInflamation ppt
Inflamation ppt
 
Inflammation
Inflammation  Inflammation
Inflammation
 
Inflammation
InflammationInflammation
Inflammation
 
Ch 3 inflammation and repair
Ch 3 inflammation and repairCh 3 inflammation and repair
Ch 3 inflammation and repair
 
Healing and repair
Healing and repairHealing and repair
Healing and repair
 
Inflammation
Inflammation Inflammation
Inflammation
 
1. inflammation with vascular events dr ashutosh kumar
1. inflammation  with vascular events dr ashutosh kumar1. inflammation  with vascular events dr ashutosh kumar
1. inflammation with vascular events dr ashutosh kumar
 
Acute inflammation(pathology)
Acute inflammation(pathology)Acute inflammation(pathology)
Acute inflammation(pathology)
 
11,12
11,1211,12
11,12
 
Acute and chronic inflammation
Acute and chronic inflammationAcute and chronic inflammation
Acute and chronic inflammation
 
Inflammation
InflammationInflammation
Inflammation
 
Inflammation (Acute and Chronic) Prof Mulazim Hussain Bukhari
Inflammation (Acute and Chronic) Prof Mulazim Hussain BukhariInflammation (Acute and Chronic) Prof Mulazim Hussain Bukhari
Inflammation (Acute and Chronic) Prof Mulazim Hussain Bukhari
 
Ch 4 hemorragic disorders,thromboembolic diseases, shock
Ch 4 hemorragic disorders,thromboembolic diseases, shockCh 4 hemorragic disorders,thromboembolic diseases, shock
Ch 4 hemorragic disorders,thromboembolic diseases, shock
 
Pathology of immune system
Pathology of immune systemPathology of immune system
Pathology of immune system
 
Inflammation part 1
Inflammation part 1Inflammation part 1
Inflammation part 1
 
Cellular responses to stress and noxious stimuli
Cellular responses to stress and noxious stimuliCellular responses to stress and noxious stimuli
Cellular responses to stress and noxious stimuli
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Inflammation
InflammationInflammation
Inflammation
 
Wound healing
Wound healingWound healing
Wound healing
 

Viewers also liked

Crwad 2011 presentation revelo
Crwad 2011 presentation reveloCrwad 2011 presentation revelo
Crwad 2011 presentation revelo
xsrevelo01
 
Le régime anti-inflammatoire dans l'athérome
Le régime anti-inflammatoire dans l'athéromeLe régime anti-inflammatoire dans l'athérome
Le régime anti-inflammatoire dans l'athérome
Pelouze Guy-André
 
Inflammation and Repair
Inflammation and RepairInflammation and Repair
Inflammation and Repair
Navid J. Ayon
 
Ppt chapter 24-1
Ppt chapter 24-1Ppt chapter 24-1
Ppt chapter 24-1
stanbridge
 
Salmonella infections
Salmonella infectionsSalmonella infections
Salmonella infections
Jasmine John
 

Viewers also liked (20)

Crwad 2011 presentation revelo
Crwad 2011 presentation reveloCrwad 2011 presentation revelo
Crwad 2011 presentation revelo
 
Acute chronic inflammation
Acute chronic inflammationAcute chronic inflammation
Acute chronic inflammation
 
Le régime anti-inflammatoire dans l'athérome
Le régime anti-inflammatoire dans l'athéromeLe régime anti-inflammatoire dans l'athérome
Le régime anti-inflammatoire dans l'athérome
 
Recovery from bacterial infections
Recovery from bacterial infections Recovery from bacterial infections
Recovery from bacterial infections
 
11 Reasons to Take Ole Olive Leaf Extract by QNET
11 Reasons to Take Ole Olive Leaf Extract by QNET11 Reasons to Take Ole Olive Leaf Extract by QNET
11 Reasons to Take Ole Olive Leaf Extract by QNET
 
11 cellular & vascular events in acute inflammation
11 cellular & vascular events in acute inflammation11 cellular & vascular events in acute inflammation
11 cellular & vascular events in acute inflammation
 
Inflammation and Repair
Inflammation and RepairInflammation and Repair
Inflammation and Repair
 
Inflamation
InflamationInflamation
Inflamation
 
02.10.09(b): Phagocytic Cells: Mechanisms of Bacterial Injury and Tissue Injury
02.10.09(b): Phagocytic Cells: Mechanisms of Bacterial Injury and Tissue Injury02.10.09(b): Phagocytic Cells: Mechanisms of Bacterial Injury and Tissue Injury
02.10.09(b): Phagocytic Cells: Mechanisms of Bacterial Injury and Tissue Injury
 
Inflammation ospe rapid review
Inflammation ospe rapid reviewInflammation ospe rapid review
Inflammation ospe rapid review
 
Ppt chapter 24-1
Ppt chapter 24-1Ppt chapter 24-1
Ppt chapter 24-1
 
Syphilis
SyphilisSyphilis
Syphilis
 
Malaria
MalariaMalaria
Malaria
 
Congenital Syphilis
Congenital SyphilisCongenital Syphilis
Congenital Syphilis
 
syphilis ppt
syphilis pptsyphilis ppt
syphilis ppt
 
Syphilis(Treponema pallidum)
Syphilis(Treponema pallidum)Syphilis(Treponema pallidum)
Syphilis(Treponema pallidum)
 
Salmonella infections
Salmonella infectionsSalmonella infections
Salmonella infections
 
Syphilis
SyphilisSyphilis
Syphilis
 
Salmonellosis
Salmonellosis Salmonellosis
Salmonellosis
 
Salmonella
Salmonella Salmonella
Salmonella
 

Similar to Lecture 6 inflammation.pptx

Inflammation (2).pptx
Inflammation (2).pptxInflammation (2).pptx
Inflammation (2).pptx
Yomif3
 

Similar to Lecture 6 inflammation.pptx (20)

lecture6inflammation-pptx-120913130832-phpapp01.pdf
lecture6inflammation-pptx-120913130832-phpapp01.pdflecture6inflammation-pptx-120913130832-phpapp01.pdf
lecture6inflammation-pptx-120913130832-phpapp01.pdf
 
Inflammation (2).pptx
Inflammation (2).pptxInflammation (2).pptx
Inflammation (2).pptx
 
Acute Inflammation for j 25
Acute Inflammation for j 25Acute Inflammation for j 25
Acute Inflammation for j 25
 
Acute inflammation
Acute inflammationAcute inflammation
Acute inflammation
 
4. acute Inflammation31.08.17 153 series.pptx
4. acute Inflammation31.08.17 153 series.pptx4. acute Inflammation31.08.17 153 series.pptx
4. acute Inflammation31.08.17 153 series.pptx
 
Acute Inflammation process in biological system.pptx
Acute Inflammation process in biological system.pptxAcute Inflammation process in biological system.pptx
Acute Inflammation process in biological system.pptx
 
Acute inflammation
Acute inflammationAcute inflammation
Acute inflammation
 
acuteinflammationacuteinflammation.pptxacuteinflammation.pptx
acuteinflammationacuteinflammation.pptxacuteinflammation.pptxacuteinflammationacuteinflammation.pptxacuteinflammation.pptx
acuteinflammationacuteinflammation.pptxacuteinflammation.pptx
 
Inflammation new.pptx shjssjidjdjksloiyzñn
Inflammation new.pptx shjssjidjdjksloiyzñnInflammation new.pptx shjssjidjdjksloiyzñn
Inflammation new.pptx shjssjidjdjksloiyzñn
 
Inflammation and repair rince
Inflammation and repair rinceInflammation and repair rince
Inflammation and repair rince
 
Inflammation Flash points By Dr Ejaz Waris
Inflammation Flash points By Dr Ejaz WarisInflammation Flash points By Dr Ejaz Waris
Inflammation Flash points By Dr Ejaz Waris
 
Inflammation notes Pathophysiology
Inflammation  notes PathophysiologyInflammation  notes Pathophysiology
Inflammation notes Pathophysiology
 
Inflammation Part 2
Inflammation Part 2Inflammation Part 2
Inflammation Part 2
 
Inflammation Part (2)
Inflammation Part  (2)Inflammation Part  (2)
Inflammation Part (2)
 
Inflammation-and-repair-lecture (1).ppt
Inflammation-and-repair-lecture (1).pptInflammation-and-repair-lecture (1).ppt
Inflammation-and-repair-lecture (1).ppt
 
Process of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptxProcess of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptx
 
Inflammation & cellular response
Inflammation & cellular responseInflammation & cellular response
Inflammation & cellular response
 
Inflammation in dentistry-SEMINAR
Inflammation in dentistry-SEMINARInflammation in dentistry-SEMINAR
Inflammation in dentistry-SEMINAR
 
Inflammation part 1
Inflammation part 1Inflammation part 1
Inflammation part 1
 
Inflammation: Introduction
Inflammation: Introduction Inflammation: Introduction
Inflammation: Introduction
 

Recently uploaded

Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo Diehl
Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo DiehlFuture Visions: Predictions to Guide and Time Tech Innovation, Peter Udo Diehl
Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo Diehl
Peter Udo Diehl
 

Recently uploaded (20)

Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo Diehl
Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo DiehlFuture Visions: Predictions to Guide and Time Tech Innovation, Peter Udo Diehl
Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo Diehl
 
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)
 
IESVE for Early Stage Design and Planning
IESVE for Early Stage Design and PlanningIESVE for Early Stage Design and Planning
IESVE for Early Stage Design and Planning
 
Demystifying gRPC in .Net by John Staveley
Demystifying gRPC in .Net by John StaveleyDemystifying gRPC in .Net by John Staveley
Demystifying gRPC in .Net by John Staveley
 
Unpacking Value Delivery - Agile Oxford Meetup - May 2024.pptx
Unpacking Value Delivery - Agile Oxford Meetup - May 2024.pptxUnpacking Value Delivery - Agile Oxford Meetup - May 2024.pptx
Unpacking Value Delivery - Agile Oxford Meetup - May 2024.pptx
 
AI presentation and introduction - Retrieval Augmented Generation RAG 101
AI presentation and introduction - Retrieval Augmented Generation RAG 101AI presentation and introduction - Retrieval Augmented Generation RAG 101
AI presentation and introduction - Retrieval Augmented Generation RAG 101
 
FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...
FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...
FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...
 
IoT Analytics Company Presentation May 2024
IoT Analytics Company Presentation May 2024IoT Analytics Company Presentation May 2024
IoT Analytics Company Presentation May 2024
 
Free and Effective: Making Flows Publicly Accessible, Yumi Ibrahimzade
Free and Effective: Making Flows Publicly Accessible, Yumi IbrahimzadeFree and Effective: Making Flows Publicly Accessible, Yumi Ibrahimzade
Free and Effective: Making Flows Publicly Accessible, Yumi Ibrahimzade
 
PLAI - Acceleration Program for Generative A.I. Startups
PLAI - Acceleration Program for Generative A.I. StartupsPLAI - Acceleration Program for Generative A.I. Startups
PLAI - Acceleration Program for Generative A.I. Startups
 
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
 
The Metaverse: Are We There Yet?
The  Metaverse:    Are   We  There  Yet?The  Metaverse:    Are   We  There  Yet?
The Metaverse: Are We There Yet?
 
How we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdfHow we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdf
 
The Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdf
The Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdfThe Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdf
The Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdf
 
Custom Approval Process: A New Perspective, Pavel Hrbacek & Anindya Halder
Custom Approval Process: A New Perspective, Pavel Hrbacek & Anindya HalderCustom Approval Process: A New Perspective, Pavel Hrbacek & Anindya Halder
Custom Approval Process: A New Perspective, Pavel Hrbacek & Anindya Halder
 
Optimizing NoSQL Performance Through Observability
Optimizing NoSQL Performance Through ObservabilityOptimizing NoSQL Performance Through Observability
Optimizing NoSQL Performance Through Observability
 
WebAssembly is Key to Better LLM Performance
WebAssembly is Key to Better LLM PerformanceWebAssembly is Key to Better LLM Performance
WebAssembly is Key to Better LLM Performance
 
AI revolution and Salesforce, Jiří Karpíšek
AI revolution and Salesforce, Jiří KarpíšekAI revolution and Salesforce, Jiří Karpíšek
AI revolution and Salesforce, Jiří Karpíšek
 
Intro in Product Management - Коротко про професію продакт менеджера
Intro in Product Management - Коротко про професію продакт менеджераIntro in Product Management - Коротко про професію продакт менеджера
Intro in Product Management - Коротко про професію продакт менеджера
 
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...Integrating Telephony Systems with Salesforce: Insights and Considerations, B...
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...
 

Lecture 6 inflammation.pptx

  • 2. DEFINITIONS  Exudation: Escape of fluid, proteins and blood cells from the vascular system into the interstitial tissue or body cavities.  Exudate: an inflammatory extra vascular fluid that has high protein concentration and much cellular debris.  Edema: an excess of fluid in the interstitial tissue or serous cavities. 2
  • 3. Introduction  Inflammation is the reaction of vascularized living tissue to local injury.  It is evoked by:  Microbial infections  Physical agents  Chemicals  Necrotic tissue  Immunologic reactions 3
  • 4. Introduction  The roles of inflammation are:  To contain and isolate injury  To destroy invading microorganisms  To inactivate toxins  To prepare the tissue or organ for healing and repair 4
  • 5. Acute Inflammation  Acute inflammation is a rapid response to an injurious agent that serves to deliver mediators of host defense—leukocytes and plasma proteins—to the site of injury.  When a host encounters an injurious agent, phagocytes that reside in all tissues try to get rid of these agents. 5
  • 6. Acute Inflammation  At the same time, phagocytes and other host cells react to the presence of the foreign or abnormal substance by liberating cytokines, lipid messengers, and the various other mediators of inflammation.  Some of these mediators act on endothelial cells in the vicinity and promote the efflux of plasma and the recruitment of circulating leukocytes to the site where the offending agent is located. 6
  • 7. Acute Inflammation - continued  As the injurious agent is eliminated and anti- inflammatory mechanisms become active, the process subsides and the host returns to a normal state of health.  If the injurious agent cannot be quickly eliminated, the result may be chronic inflammation. 7
  • 8. Acute Inflammation  Acute inflammation has three major components:  alterations in vascular caliber that lead to an increase in blood flow;  structural changes in the microvasculature that permit plasma proteins and leukocytes to leave the circulation; and  emigration of the leukocytes from the microcirculation, their accumulation in the focus of injury, and their activation to eliminate the offending agent 8
  • 9. Acute Inflammation  These changes produce the classic clinical signs of inflammation:  Heat (Calor)  Redness (Rubor)  Edema (tumor)  Pain (dolor)  Loss of function 9
  • 10. 10
  • 11.  Acute inflammatory reactions are triggered by a variety of stimuli: Infections (bacterial, viral, parasitic) and microbial toxins • Trauma (blunt and penetrating) • Physical and chemical agents (thermal injury, e.g., burns or frostbite; irradiation; some environmental chemicals) • Tissue necrosis (from any cause) • Foreign bodies (splinters, dirt, sutures) • Immune reactions (also called hypersensitivity reactions) 11
  • 12. Changes in vascular flow and caliber  Initially, transient vasoconstriction of arterioles occurs  Vasodilation follows, causing increased flow; it accounts for the heat and redness  Eventually slowing of the circulation occurs as a result of increased vascular permeability, leading to stasis. (edema)  With slowing, leukocytic margination appears. 12
  • 13. 13
  • 14. Vasodilation  Brief arteriolar vasoconstriction followed by vasodilation  Accounts for warmth and redness  Opens microvascular beds  Increased intravascular pressure causes an early transudate (protein-poor filtrate of plasma) into interstitium (vascular permeability still not increased yet)
  • 15. Increased vascular permeability  Leads to escape of protein rich fluid into the intestitium.  There is increased hydrostatic pressure, caused by vasodilatation, decreased osmotic pressure due to leakage of a high protein fluid, resulting in marked outflow of fluid and edema formation. 15
  • 16. Vascular leakage  Five mechanisms known to cause vascular leakiness  Histamines, bradykinins, leukotrienes cause an early, brief (15 – 30 min.) immediate transient response in the form of endothelial cell contraction that widens intercellular gaps of venules (not arterioles, capillaries)
  • 17. Vascular leakage  Cytokine mediators (TNF, IL-1) induce endothelial cell junction retraction through cytoskeleton reorganization (4 – 6 hrs post injury, lasting 24 hrs or more)  Severe injuries may cause immediate direct endothelial cell damage (necrosis, detachment) making them leaky until they are repaired (immediate sustained response), or may cause delayed damage as in thermal or UV injury,
  • 18. Vascular leakage  (cont’d) or some bacterial toxins (delayed prolonged leakage)  Marginating and endothelial cell-adherent leukocytes may pile-up and damage the endothelium through activation and release of toxic oxygen radicals and proteolytic enzymes (leukocyte-dependent endothelial cell injury) making the vessel leaky
  • 19. Vascular leakage  Certain mediators (VEGF) may cause increased transcytosis via intracellular vesicles which travel from the luminal to basement membrane surface of the endothelial cell  All or any combination of these events may occur in response to a given stimulus
  • 20. Cellular events: Leukocyte extravasation and phagocytosis  Delivers leukocytes to the site of injury.  Sequence of events can be divided into:  Margination, rolling and adhesion to the lumen  Diapedesis  Migration in the endothelial tissues towards a chemotactic stimulus. 20
  • 21. Adhesion and Transmigration  Occurs as a result of interaction between adhesion molecules on the leukocytes and endothelium.  Major ligand-receptor pairs include:  Selectins (E, P and L)  Immunoglobulins family: ICAM and VCAM-1  The integrins 21
  • 25. 25
  • 26. Chemotaxis and leukocyte activation  Adherent leukocytes emigrate through interendothelial junctions, traverse the basement membrane and move towards the site of injury along a gradient of chemotactic agents.  Neutrophils emigrate first and they are followed by monocytes and lymphocytes. 26
  • 27. Chemotaxis and leukocyte activation  Chemotactic agents include: bacterial products, complement fragments (C5a), leukotrienes, and chemokines (IL-8).  These agents bind to specific receptors on leukocyte, resulting in signal transduction process, which results in assembly of the contractile elements responsible for cell movement. 27
  • 28. 28
  • 29. Chemotaxis and leukocyte activation  Chemotactic agents also cause leukocyte activation characterized by:  Degranulation and secretion of enzymes  Activation of an oxidative burst  Production of arachidonic acid metabolites  Modulation of leukocyte adhesion molecules 29
  • 30. Phagocytosis  Involves 3 steps:  Recognition and attachment of the paricle to be ingested. Facilitated by opsonization e.g. Fc fragment of IgG.  Engulfment by pseudopods, with formation of a phagocytic vesicle, which fuses with membrane of the lysosome to form a phagolysosome.  Killing and degranulation of bacteria. 30
  • 31. Phagocytosis  There are 2 types of bactericidal mechanisms:  Oxygen dependent mechanisms: this involves production of reactive oxygen species catalysed by enzymes such as: NADPH oxidase and myeloperoxidase  Oxygen independent mechanisms: these cause increased permeability of the bacterial cell membrane. 31
  • 32. 32
  • 33. Oxidative burst  Reactive oxygen species formed through oxidative burst that includes:  Increased oxygen consumption  Glycogenolysis  Increased glucose oxidation  Formation of superoxide ion  2O2 + NADPH  2O2-rad + NADP+ + H+ (NADPH oxidase)  O2 + 2H+  H2O2 (dismutase)
  • 34. Reactive oxygen species  Hydrogen peroxide alone insufficient  Myeloperoxidase oxidase (azurophilic granules) converts hydrogen peroxide to HOCl- (in presence of Cl- ), an oxidant/antimicrobial agent  Therefore, PMNs can kill by halogenation, or lipid/protein peroxidation
  • 35. Degradation and Clean-up  Reactive end-products only active within phagolysosome  Hydrogen peroxide broken down to water and oxygen by catalase  Dead microorganisms degraded by lysosomal acid hydrolases
  • 36. Leukocyte granules  Other antimicrobials in leukocyte granules:  Bactericidal permeability increasing protein (BPI)  Lysozyme  Lactoferrin  Defensins (punch holes in membranes)
  • 37. Leukocyte induced tissue injury  Leukocytes also release some of their products into the extracellular space. These include:  Lysosomal enzymes  Oxygen derived active metabolites  Products of arachidonic acid metabolism such as prostaglandins and leukotrienes.  these may cause tissue damage and if persistent may result in chronic inflammation. 37
  • 38. Defects in leukocyte function  May interfere with inflammation and increase susceptibility to infection.  They may be :  Acquired such as neutropenia  Genetic such as:  Defects in leukocyte adhesion  Defects in phagocytosis such as Chediak-Higashi syndrome  Defects in microbicidal activity 38
  • 39. Defects of leukocyte function  Defects of adhesion:  Defect in E- and P-selectin sugar epitopes (LAD-2)  Defects of chemotaxis/phagocytosis:  Microtubule assembly defect leads to impaired locomotion and lysosomal degranulation (Chediak- Higashi Syndrome)  Defects of microbicidal activity:  Deficiency of NADPH oxidase that generates superoxide, therefore no oxygen-dependent killing mechanism (chronic granulomatous disease)
  • 40. Outcome of acute inflammation  Complete resolution with restoration of the site to normal  Abscess formation  Healing by connective tissue replacement (fibrosis) and scarring.  Progression to chronic inflammation. 40